Lindbrook Capital’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $2.14K | Buy |
241
+122
| +103% | +$1.08K | ﹤0.01% | 2269 |
|
|
2024
Q4 | $1.63K | Sell |
119
-32
| -21% | -$439 | ﹤0.01% | 2363 |
|
|
2024
Q3 | $4.14K | Buy |
151
+3
| +2% | +$82 | ﹤0.01% | 2090 |
|
|
2024
Q2 | $3.62K | Buy |
148
+45
| +44% | +$1.1K | ﹤0.01% | 2136 |
|
|
2024
Q1 | $2.2K | Hold |
103
| – | – | ﹤0.01% | 2210 |
|
|
2023
Q4 | $1.97K | Buy |
+103
| New | +$1.97K | ﹤0.01% | 2266 |
|
|
2023
Q3 | – | Sell |
-17
| Closed | -$394 | – | 2792 |
|
|
2023
Q2 | $394 | Sell |
17
-57
| -77% | -$1.32K | ﹤0.01% | 2556 |
|
|
2023
Q1 | $1.72K | Buy |
+74
| New | +$1.72K | ﹤0.01% | 2305 |
|